Gastrointestinal Cancer
From the Journals
Pandemic-related CRC screening delays affect older adults most
Since previously unscreened 65-year-olds lose the most benefit from delayed colorectal cancer screenings, they should be prioritized when access...
Conference Coverage
High BMI linked to better survival for cancer patients treated with ICI, but for men only
The reasons behind the findings and implications for treatment are unknown, as is whether it applies to patients with specific cancers.
From the Journals
Sugary drinks linked to obesity-related cancer deaths
In addition, consuming artificially sweetened beverages was linked to an increased risk of death from pancreatic cancer.
Latest News
Novel blood test for early-stage liver cancer shows promise
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
From the Journals
Annual screening benefits people at high-risk for pancreatic cancer
Opponents of screening suggested while screening may identify cancer earlier, it doesn’t necessarily improve outcomes.
Conference Coverage
‘Unprecedented’ responses to neoadjuvant treatment in dMMR colon cancer
Neoadjuvant immunotherapy “has the potential to become standard of care” in these patients.
Conference Coverage
First drug for desmoid tumors: ‘Impressive’ data for nirogacestat
Nirogacestat has shown a significant improvement in progression-free survival and also a reduction in symptoms and better quality of life.
News
Inhibiting adenosine pathways may be key to CRC treatment
New research suggests mechanisms behind how adenosine leads to immunosuppression in the tumor microenvironment.
From the Journals
After index colonoscopy, what’s the CRC risk in 40- to 49-year-olds vs. 50- to 59-year-olds?
Advanced neoplasia risk is lower in younger patients when no adenoma is detected on index colonoscopy, new research indicates.